SCHEMBL30108044

SCHEMBL30108044

CSc1nc(-c2ccco2)cc(-n2nnc3cc(B(O)O)ccc32)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
HPGD P15428 7/20 0.40
KDM4E B2RXH2 6/20 0.40
TSHR P16473 6/20 0.40
HSD17B10 Q99714 4/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
POLB P06746 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 3/20 0.36
BLM P54132 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
HTT P42858 2/20 0.36
GAPDH P04406 1/20 0.36
ALOX15 P16050 1/20 0.36
NR4A1 P22736 1/20 0.36
PTPN7 P35236 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108040 0.85 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30108032 0.81 KDM4E (0.47) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30108073 0.79 LPL (0.40) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30107959 0.71 KDM4E (0.44) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30107951 0.69 PTGS1 (0.46) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30107973 0.69 KDM4E (0.46) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30108014 0.69 KDM4E (0.42) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30108023 0.68 PTGS1 (0.47) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL30108012 0.68 TSHR (0.58) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL5022427 0.64 ADORA2B (0.49) ALDH1A1HPGDKDM4ETSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed